Clinic News

Latest in Cardiology

ACCEL Lite: ACCEL Lite: Top Takeaways from 2025: Clinical Cardiology with Allen J. Taylor, MD, FACC
In this interview, Allen J. Taylor, MD, FACC and Alison L. Bailey, MD FACC, discuss the Top Clinical Cardiology Takeaways from 2025 including trials SCOT-HEART 2, ALONE-AF, Launch-HTN, and more.
ACC CardiaCast: Pharmacological and Nonpharmacological Interventions for the Prevention of HF
In this episode, Alison Bailey, MD, FACC, and Melvin R. Echols, MD, FACC, discuss current pharmacological and nonpharmacological interventions to prevent and/or decrease the progression of heart failure (HF).
Driving Community-Based Change at the Heart of New Fuster Prevention Forum
ACC's newly launched Fuster Prevention Forum, designed to honor the contributions of Valentin Fuster, MD, PhD, MACC, and his lifelong commitment to establishing a culture of prevention, will teach clinicians effective ways to educate children, parents and educators in their communities on nutrition, physical activity and emotional well-being.
2025 ACC/AHA Sports Participation Guidelines For Athletes With CV Abnormalities: A Paradigm Shift Toward Shared Decision-Making
The 2025 American Heart Association/American College of Cardiology (AHA/ACC) scientific statement on Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities provides evolving insights and clinical guidance in the field of sports cardiology.
Eagleâ€™s Eye View: A Change in Food Labeling to Improve CV Health
In this weekâ€™s View, Dr. Eagleâ€¯looksâ€¯atâ€¯theâ€¯use of PREVENTâ€¯equations to assessâ€¯cardiovascularâ€¯(CV)â€¯diseaseâ€¯risk and the CREST-2â€¯randomized trialsâ€¯that examined stentingâ€¯versusâ€¯endarterectomyâ€¯for asymptomatic carotid disease.
ACCEL Lite: ACCEL Lite: Top Takeaways from 2025: Interventional Cardiology with Deepak Bhatt, MD, MPH, MBA, FACC
In this interview, Deepak Bhatt, MD, MPH, FACC and Alison L. Bailey, MD FACC, discuss the Top Interventional Cardiology Takeaways from 2025 including DanGer Shock trial, revascularization in STEMI, aspirin withdrawal after PCI, and more.
ACC Issues Guidance For Managing CV Risks Associated With Cancer Treatments
With modern cancer therapeutics changing the landscape of cancer treatment, the need to address cardiovascular treatment-related complications is increasingly important.
Is LBBAP Feasible in Patients With Cardiac Sarcoidosis?
In patients with cardiac sarcoidosis (CS), left bundle branch area pacing (LBBAP) is feasible and provides stable long-term lead performance, according to a single-center retrospective study published Nov. 21 in JACC: Clinical Electrophysiology.
Does Early Life Famine Exposure Increase T2D, HTN or CV Hospitalization Risk?
Early life exposure to famine was strongly associated with increased risks of incident type 2 diabetes (T2D) and hypertension, but not cardiovascular hospitalization, according to a population-based cohort study published Nov. 25 in JAMA.
New Proposed Criteria For Monitoring Disease Progression in ATTR-CM
Recognizing a need to update the 2021 criteria for monitoring disease progression in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a group of international experts shared new proposed criteria, including recommendations for thresholds and monitoring frequency, in a recent Position Statement published in JACC: Heart Failure.